Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company It also provides other products, such as Akynzeo, Aloxi, Ammonul, Betapred, Caphosol, Fibclot, IVheBex, and Willfact. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Apellis Pharmaceuticals Inc. to develop pegcetacoplan for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden. Show More...
-
Website http://www.sobi.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 293.20 SEK
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share SEK -0.47 0.07 -0.38 -0.35 -1.01 0.24 2.98 4.25 8.93 11.22 12.08 Dividends SEK Payout Ratio % * Shares Mil 199.0 242.0 265.0 265.0 266.0 267.0 269.0 270.0 271.0 295.0 296.0 Book Value Per Share * SEK 39.04 43.55 18.8 17.97 17.0 17.34 19.98 23.59 31.49 53.3 63.38 Free Cash Flow Per Share * SEK -1.25 -0.24 1.25 -0.28 0.5 1.04 0.77 3.48 4.5 -20.16 Return on Assets % -2.11 0.26 -1.55 -1.45 -4.16 0.93 8.85 11.0 17.22 10.52 9.38 Financial Leverage (Average) 1.62 1.35 1.31 1.36 1.41 1.77 1.86 1.63 1.9 2.7 2.48 Return on Equity % -3.67 0.39 -2.06 -1.94 -5.76 1.48 16.11 19.06 30.72 25.44 21.63 Return on Invested Capital % -2.0 1.12 -1.14 -0.92 -4.12 2.01 12.28 14.48 29.26 16.36 13.03 Interest Coverage -4.91 -1.49 -1.04 -4.63 2.6 14.34 24.95 55.58 18.62 Current Ratio 2.08 2.43 3.25 2.67 2.59 1.75 1.66 1.76 0.95 1.28 1.3 Quick Ratio 0.66 0.85 1.73 1.45 1.46 1.11 1.07 1.26 0.74 0.93 0.99 Debt/Equity 0.45 0.12 0.17 0.18 0.17 0.43 0.16 0.97 0.82